TRPA1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-91319
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat, Monkey
Cited:
Human, Mouse, Rat
Applications
Validated:
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Cited:
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Product Specifications
Immunogen
A synthetic peptide from rat TRPA1 conjugated to blue carrier protein was used as the antigen. The peptide is homologous in mouse.
Reactivity Notes
Marmoset
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Theoretical MW
128 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for TRPA1 Antibody
Western Blot: TRPA1 Antibody [NB100-91319]
Western Blot: TRPA1 Antibody [NB100-91319] - Tissue lysates. Blocking: 1% LFDM for 30 min at RT; primary antibody: dilution 1:6000 incubated overnight at 4C.Western Blot: TRPA1 Antibody [NB100-91319] -
Western Blot: TRPA1 Antibody [NB100-91319] - TRPA1 inhibitor HC030031 significantly ameliorated the oxidative stress & apoptosis levels of Pg.LPS-induced PDLCs. (a) P.g.LPS increased intracellular calcium ion level in a dose-dependent manner (n = 3). (b) Lower HC030031 concentration significantly reversed the increase of intracellular calcium ions, & 10 μM HC030031 was used in the subsequent experiment (n = 3). (c) Flow cytometry analysis of the control group (PDLCs only, C), L group (PDLCs treated by LPS, L), & LH group (PDLCs treated by 10 μM HC030031 & LPS, LH) (n = 4). (d, e) Western blot analysis & semiquantitative statistical analysis of oxidative stress, apoptosis, & TRPA1 proteins in in C, L, & LH groups (n = 3). (f) EM images showing endoplasmic reticulum (yellow arrows) & mitochondrial morphology (red arrows) of PDLCs in Ctr, LPS, & LH groups (white stars represent cell nuclei) (n = 4). (g) Quantification of endoplasmic reticulum size, mitochondrial size, mitochondrial number per cell (n = 4), & mitochondrial crista density was analyzed (>100 mitochondria). Data analysis was performed by using one-way ANOVA (∗P < 0.05, ∗∗P < 0.01, & ∗∗∗P < 0.001). Data are presented as the mean ± SEM. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/35720191), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: TRPA1 Antibody [NB100-91319] -
Western Blot: TRPA1 Antibody [NB100-91319] - Periodontitis-derived periodontal ligament cells & tissues were at high levels of oxidative stress & apoptosis. (a) The related gene expressions of oxidative stress, apoptosis, & some of the TRP families in healthy & periodontitis-derived periodontal ligament cells (PDLCs & P-PDLCs) (n = 3). (b, c) Western blot & semiquantitative statistical analysis of oxidative stress, apoptosis, & TRPA1 in PDLCs & P-PDLCs. (n = 3). d, Flow cytometry analysis of PDLCs & P-PDLCs (n = 4). (e, f) H&E staining (white star represent immune cell infiltration), immunohistochemistry & immunofluorescence staining, & semiquantitative statistical analysis of periodontitis & healthy derived periodontal ligament tissues (PDLTs & P-PDLTs) (n = 3). Data analysis was performed by using Student's t-test (∗P < 0.05, ∗∗P < 0.01, & ∗∗∗P < 0.001). The data are presented as the mean ± SEM. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/35720191), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Applications for TRPA1 Antibody
Application
Recommended Usage
Immunohistochemistry
1 : 300 - 1 : 2000
Immunohistochemistry-Paraffin
1:2000
Western Blot
1:1000
Application Notes
Use in Immunocytochemistry/immunofluorescence reported in scientific literature (PMID: 30707612).
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Unpurified
Reconstitution
Reconstitute in 0.1 ml of sterile water. Centrifuge to remove any insoluble material. Glycerol may be added (1:1) for additional stability. Please note the sample size is provided in reconstituted format.
Formulation
Lyophilized from whole antisera
Preservative
No Preservative
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TRPA1
Long Name
Transient receptor potential cation channel subfamily A member 1
Alternate Names
ANKTM1, Wasabi receptor
Gene Symbol
TRPA1
UniProt
Additional TRPA1 Products
Product Documents for TRPA1 Antibody
Product Specific Notices for TRPA1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...